Search research articles
Contact Us
Filters
Showing results (101-110 of 153) with videos related to
Page
of 16
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
March 30, 2025
Optimizing antibody PET imaging: a comparative preclinical analysis of nanobody and minibody-like PET tracers
Katty Zeven, Herlinde Dierick, Matthijs Sevenois, et al.
Nature Communications
|
February 24, 2023
Molecular imaging of liver inflammation using an anti-VCAM-1 nanobody
Maxime Nachit, Christopher Montemagno, Romain Clerc, et al.
Cancer Research
|
June 22, 2012
Nanobody-based targeting of the macrophage mannose receptor for effective in vivo imaging of tumor-associated macrophages
Kiavash Movahedi, Steve Schoonooghe, Damya Laoui, et al.
Frontiers in Immunology
|
May 9, 2024
Scrutiny of chimeric antigen receptor activation by the extracellular domain: experience with single domain antibodies targeting multiple myeloma cells highlights the need for case-by-case optimization
Heleen Hanssens, Fien Meeus, Yannick De Vlaeminck, et al.
Frontiers in Pharmacology
|
October 2, 2023
Safety assessment of fluorescently labeled anti-EGFR Nanobodies in healthy dogs
Nayra Cristina Herreira do Valle, Simone Janssen, Marcus C M Stroet, et al.
Frontiers in Immunology
|
December 17, 2021
Imaging of Glioblastoma Tumor-Associated Myeloid Cells Using Nanobodies Targeting Signal Regulatory Protein Alpha
Karen De Vlaminck, Ema Romão, Janik Puttemans, et al.
Biomolecules
|
October 2, 2020
Anti-human PD-L1 Nanobody for Immuno-PET Imaging: Validation of a Conjugation Strategy for Clinical Translation
Jessica Bridoux, Katrijn Broos, Quentin Lecocq, et al.
Frontiers in Immunology
|
July 22, 2022
Radiotheranostic Agents in Hematological Malignancies
Jo Caers, Elodie Duray, Louise Vrancken, et al.
The Journal of Biological Chemistry
|
December 25, 2014
Generation and characterization of small single domain antibodies inhibiting human tumor necrosis factor receptor 1
Sophie Steeland, Leen Puimège, Roosmarijn E Vandenbroucke, et al.
Molecular Therapy. Oncology
|
December 11, 2025
Preclinical development and selection of nanobody-based CAR-T cells targeting HER2-positive solid tumors
Fien Meeus, Arne Van der Vreken, Dorien Autaers, et al.
Page
of 16
Search research articles
Search
Showing results (101-110 of 153) with videos related to
Sort By:
Page
of 16
European Journal of Nuclear Medicine and Molecular Imaging
|
March 30, 2025
Optimizing antibody PET imaging: a comparative preclinical analysis of nanobody and minibody-like PET tracers
Katty Zeven, Herlinde Dierick, Matthijs Sevenois, et al.
Nature Communications
|
February 24, 2023
Molecular imaging of liver inflammation using an anti-VCAM-1 nanobody
Maxime Nachit, Christopher Montemagno, Romain Clerc, et al.
Cancer Research
|
June 22, 2012
Nanobody-based targeting of the macrophage mannose receptor for effective in vivo imaging of tumor-associated macrophages
Kiavash Movahedi, Steve Schoonooghe, Damya Laoui, et al.
Frontiers in Immunology
|
May 9, 2024
Scrutiny of chimeric antigen receptor activation by the extracellular domain: experience with single domain antibodies targeting multiple myeloma cells highlights the need for case-by-case optimization
Heleen Hanssens, Fien Meeus, Yannick De Vlaeminck, et al.
Frontiers in Pharmacology
|
October 2, 2023
Safety assessment of fluorescently labeled anti-EGFR Nanobodies in healthy dogs
Nayra Cristina Herreira do Valle, Simone Janssen, Marcus C M Stroet, et al.
Frontiers in Immunology
|
December 17, 2021
Imaging of Glioblastoma Tumor-Associated Myeloid Cells Using Nanobodies Targeting Signal Regulatory Protein Alpha
Karen De Vlaminck, Ema Romão, Janik Puttemans, et al.
Biomolecules
|
October 2, 2020
Anti-human PD-L1 Nanobody for Immuno-PET Imaging: Validation of a Conjugation Strategy for Clinical Translation
Jessica Bridoux, Katrijn Broos, Quentin Lecocq, et al.
Frontiers in Immunology
|
July 22, 2022
Radiotheranostic Agents in Hematological Malignancies
Jo Caers, Elodie Duray, Louise Vrancken, et al.
The Journal of Biological Chemistry
|
December 25, 2014
Generation and characterization of small single domain antibodies inhibiting human tumor necrosis factor receptor 1
Sophie Steeland, Leen Puimège, Roosmarijn E Vandenbroucke, et al.
Molecular Therapy. Oncology
|
December 11, 2025
Preclinical development and selection of nanobody-based CAR-T cells targeting HER2-positive solid tumors
Fien Meeus, Arne Van der Vreken, Dorien Autaers, et al.
Page
of 16